Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease - PubMed (original) (raw)

. 2006 Oct;93(10):1290-6.

doi: 10.1002/bjs.5431.

Affiliations

• PMID: 16838391
• DOI: 10.1002/bjs.5431

Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease

D Beddy et al. Br J Surg. 2006 Oct.

Abstract

Background: Connective tissue growth factor (CTGF) stimulates fibroblast proliferation and extracellular matrix production. Fibroblasts may initiate stricture formation in Crohn's disease through overexpression of CTGF. Stricturing that occurs in patients with Crohn's disease after treatment with anti-tumour necrosis factor (TNF) alpha may be due to dysregulation of CTGF homeostasis. The aim of this study was to examine CTGF expression and regulation in fibroblasts isolated from patients with Crohn's disease.

Methods: Fibroblasts were isolated by a primary explant technique from serosal biopsies of strictured segments of bowel in eight patients undergoing resection for Crohn's disease and from normal colon in seven patients having resection for benign or malignant colorectal disease. Cells were stimulated with transforming growth factor (TGF) beta and TNF-alpha. CTGF protein and mRNA expression were measured by western blotting and real-time polymerase chain reaction respectively.

Results: Mean(s.d.) CTGF protein expression in strictured Crohn's fibroblasts was higher than that in normal fibroblasts (56.5(9.7) versus 17.0(10.0) respectively; P = 0.011). In normal and strictured Crohn's fibroblasts, culture with TGF-beta increased CTGF protein and mRNA expression. Co-culture of normal fibroblasts with TNF-alpha suppressed TGF-beta-stimulated CTGF expression.

Conclusion: : Increased expression of CTGF in strictured Crohn's fibroblasts underlies its role in fibrosis. TNF-alpha suppresses fibrosis by downregulating fibroblast CTGF expression, an effect that may be lost following anti-TNF-alpha treatment, thereby promoting stricture formation.

PubMed Disclaimer

Similar articles

• Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
  Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR. Mulsow JJ, et al. Ann Surg. 2005 Dec;242(6):880-7, discussion 887-9. doi: 10.1097/01.sla.0000189606.58343.cd. Ann Surg. 2005. PMID: 16327498 Free PMC article.
• Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease.
  Beddy D, Watson RW, Fitzpatrick JM, O'Connell PR. Beddy D, et al. Br J Surg. 2004 Jan;91(1):72-7. doi: 10.1002/bjs.4453. Br J Surg. 2004. PMID: 14716797
• Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
  Burke JP, Ferrante M, Dejaegher K, Watson RW, Docherty NG, De Hertogh G, Vermeire S, Rutgeerts P, D'Hoore A, Penninckx F, Geboes K, Van Assche G, O'Connell PR. Burke JP, et al. Inflamm Bowel Dis. 2008 Sep;14(9):1197-204. doi: 10.1002/ibd.20482. Inflamm Bowel Dis. 2008. PMID: 18452219
• The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology.
  Leask A, Abraham DJ. Leask A, et al. Biochem Cell Biol. 2003 Dec;81(6):355-63. doi: 10.1139/o03-069. Biochem Cell Biol. 2003. PMID: 14663501 Review.
• Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.
  Grotendorst GR. Grotendorst GR. Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9. doi: 10.1016/s1359-6101(97)00010-5. Cytokine Growth Factor Rev. 1997. PMID: 9462483 Review.

Cited by

• The rs9402373 polymorphism of CTGF gene may not be related to inflammatory bowel disease susceptibility in Chinese population based on ARMS-PCR genotyping.
  Xie Y, Ping Y, Yu P, Liu W, Chen X, Wang Q, Chen Y, Duan X, Wang X. Xie Y, et al. Heliyon. 2023 Jun 5;9(6):e17003. doi: 10.1016/j.heliyon.2023.e17003. eCollection 2023 Jun. Heliyon. 2023. PMID: 37484218 Free PMC article.
• Total Flavone of Abelmoschus manihot Ameliorates TNBS-Induced Colonic Fibrosis by Regulating Th17/Treg Balance and Reducing Extracellular Matrix.
  Qiao L, Fang L, Zhu J, Xiang Y, Xu H, Sun X, Chen H, Yang B. Qiao L, et al. Front Pharmacol. 2021 Dec 23;12:769793. doi: 10.3389/fphar.2021.769793. eCollection 2021. Front Pharmacol. 2021. PMID: 35002710 Free PMC article.
• Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells.
  Estrada HQ, Patel S, Rabizadeh S, Casero D, Targan SR, Barrett RJ. Estrada HQ, et al. Inflamm Bowel Dis. 2022 May 4;28(5):667-679. doi: 10.1093/ibd/izab292. Inflamm Bowel Dis. 2022. PMID: 34918082 Free PMC article.
• Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.
  Lin SN, Mao R, Qian C, Bettenworth D, Wang J, Li J, Bruining DH, Jairath V, Feagan BG, Chen MH; Stenosis Therapy and Antifibrotic Research (STAR) Consortium; Rieder F. Lin SN, et al. Physiol Rev. 2022 Apr 1;102(2):605-652. doi: 10.1152/physrev.00005.2021. Epub 2021 Sep 27. Physiol Rev. 2022. PMID: 34569264 Free PMC article. Review.
• Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation.
  Amamou A, Rouland M, Yaker L, Goichon A, Guérin C, Aziz M, Savoye G, Marion-Letellier R. Amamou A, et al. Sci Rep. 2021 Jul 23;11(1):15055. doi: 10.1038/s41598-021-94280-8. Sci Rep. 2021. PMID: 34301970 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems
  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal